The hypoxia-inducible miR-182 was reported to target two different RasGAPs: RASA1 in hepatocellular cancer and oral cavity squamous cells carcinoma, and DAB2IP in colorectal carcinoma [77,78,79]. Here, DAB2IP is linked to hepatocellular carcinoma.